Jan N Basile Selected Research

Sodium-Glucose Transport Proteins

5/2013

The potential of sodium glucose cotransporter 2 (SGLT2) inhibitors to reduce cardiovascular risk in patients with type 2 diabetes (T2DM).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jan N Basile Research Topics

Disease

19	Hypertension (High Blood Pressure) 12/2020 - 09/2003
14	Myocardial Infarction 10/2016 - 03/2004
11	Stroke (Strokes) 10/2016 - 01/2002
9	Heart Failure 10/2016 - 02/2002
7	Cardiovascular Diseases (Cardiovascular Disease) 10/2013 - 03/2004
6	Type 2 Diabetes Mellitus (MODY) 10/2016 - 04/2010
4	Chronic Kidney Failure (Chronic Renal Failure) 09/2008 - 05/2007
3	Dyslipidemias (Dyslipidemia) 10/2013 - 09/2008
3	Chronic Renal Insufficiency 10/2013 - 05/2007
2	Diabetes Mellitus 10/2016 - 03/2004
2	Coronary Disease (Coronary Heart Disease) 01/2012 - 03/2004
2	Peripheral Arterial Disease 09/2006 - 03/2004
1	Orthostatic Hypotension (Postural Hypotension) 10/2016
1	Isolated Systolic Hypertension 04/2016
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2016
1	Body Weight (Weight, Body) 05/2013
1	Hyperglycemia 05/2013
1	Obstructive Sleep Apnea 02/2013
1	Hyperaldosteronism (Conn Syndrome) 08/2011
1	Glucose Intolerance 11/2010
1	Neoplasms (Cancer) 09/2010
1	Dementia (Dementias) 06/2010
1	Alzheimer Disease (Alzheimer's Disease) 06/2010
1	Osteoarthritis 03/2010
1	Flushing 04/2009
1	Proteinuria 09/2008
1	Kidney Diseases (Kidney Disease) 09/2008
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2008
1	Anemia 12/2007
1	Angioedema 09/2006
1	Hemorrhage 09/2006
1	Insulin Resistance 03/2004
1	Pain (Aches) 09/2002
1	Ischemic Stroke 01/2002
1	Cough 01/2002

Drug/Important Bio-Agent (IBA)

14	Antihypertensive Agents (Antihypertensives)IBA 12/2020 - 09/2003
10	LipidsIBA 11/2014 - 03/2004
7	Pharmaceutical PreparationsIBA 01/2016 - 09/2003
5	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2012 - 01/2002
4	Chlorthalidone (Chlortalidone)FDA LinkGeneric 01/2012 - 03/2004
4	Lisinopril (Prinivil)FDA LinkGeneric 01/2012 - 09/2006
4	Angiotensin Receptor AntagonistsIBA 11/2010 - 11/2008
3	DiureticsIBA 01/2012 - 03/2003
3	Amlodipine (Norvasc)FDA LinkGeneric 01/2012 - 09/2006
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2013 - 09/2008
2	Pravastatin (Pravachol)FDA LinkGeneric 10/2013 - 09/2008
2	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2012 - 09/2006
2	Triglycerides (Triacylglycerol)IBA 04/2009 - 01/2008
2	HDL CholesterolIBA 04/2009 - 01/2008
2	Glucose (Dextrose)FDA LinkGeneric 01/2008 - 03/2004
2	Doxazosin (Cardura)FDA LinkGeneric 01/2008 - 03/2004
1	hydroxide ionIBA 10/2016
1	CreatinineIBA 04/2016
1	Hypoglycemic Agents (Hypoglycemics)IBA 05/2013
1	Sodium-Glucose Transport ProteinsIBA 05/2013
1	Sodium-Glucose Transporter 2 InhibitorsIBA 05/2013
1	Eplerenone (Inspra)FDA LinkGeneric 08/2011
1	Spironolactone (Aldactone)FDA LinkGeneric 08/2011
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 03/2010
1	ReninIBA 07/2009
1	AngiotensinsIBA 07/2009
1	ceramide heptassaccharide (CHSC)IBA 07/2009
1	SodiumIBA 07/2009
1	Niacin (Nicotinic Acid)FDA LinkGeneric 04/2009
1	Simvastatin (Zocor)FDA LinkGeneric 04/2009
1	Atorvastatin (Lipitor)FDA Link 04/2009
1	oxidized low density lipoproteinIBA 04/2009
1	Telmisartan (Micardis)FDA Link 11/2008
1	CholesterolIBA 09/2008
1	LDL CholesterolIBA 09/2008
1	HDL LipoproteinsIBA 09/2008
1	HematinicsIBA 12/2007
1	Narcotics (Narcotic Analgesics)IBA 09/2002
1	IronIBA 01/2002

Therapy/Procedure

19	Therapeutics 04/2016 - 02/2002
1	Sympathectomy (Sympathectomies) 05/2014
1	Continuous Positive Airway Pressure 02/2013
1	Renal Replacement Therapy (Therapies, Renal Replacement) 05/2007
1	Contraindications 03/2003
1	Estrogen Replacement Therapy 01/2002